Research teams from different corners of the world presented studies that are characterized by a high level of innovation. In addition to the evaluation of already established therapy options, numerous preclinical and clinical studies were presented, the long-term goal of which is to expand the treatment options for acne, rosacea, atopic dermatitis and psoriasis. State-of-the-art molecular and cell biology, genomic and immunodiagnostic methods were used for this purpose.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Cardiogenic shock - 2025 update
Between standardization, team processes and targeted cycle support
- Collagenoses
Scleroderma – Current recommendations for diagnosis and therapy 2025
- Multiple sclerosis
Avoiding the nocebo trap with natalizumab biosimilars
- COPD and comorbidities
Exacerbation frequency is associated with cardiopulmonary disease burden
- Multiple myeloma
DREAMM-8: Key study in the development of BCMA therapy up to DREAMM-14
- Catheter ablation for atrial fibrillation 2025
Pulsed field versus radio frequency – where do we stand?
- Atopic dermatitis
From skin barrier disorder to atopic march?
- From the late residual valve to independent therapy